Prospect of Prostate Cancer Treatment: Armed CAR-T or Combination Therapy

Prospect of Prostate Cancer Treatment: Armed CAR-T or Combination Therapy

The incidence rate of prostate cancer is higher in male cancers. With a hidden initiation of disease and long duration, prostate cancer seriously affects men’s physical and mental health. Prostate cancer is initially androgen-dependent, and endocrine therapy can achieve good results. However, after...

Full description

Bibliographic Details
Main Authors: Yao Jiang, Weihong Wen, Fa Yang, Donghui Han, Wuhe Zhang, Weijun Qin
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
CAR-T cell therapy
immunotherapy
prostate cancer
anti-PD-L1
checkpoint inhibitor
Online Access:https://www.mdpi.com/2072-6694/14/4/967

Similar Items

Similar Items